Catalyst Pharm Inc (CPRX)
$3.89
0.01 (0.26%)
18:54 EST
CPRX Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
399.10M
PE Ratio
-18.52
EPS
-0.21
Volume (Avg. Vol.)
1.25M
Day's Range
3.83 - 4.04
52-Week Range
2.55 - 5.19
Dividend & Yield
N/A (N/A)
CPRX Stock Predictions, Articles, and Catalyst Pharm Inc News
- From InvestorPlace
- From the Web
7 Penny Stock Companies That Actually Make Money
Penny stocks are low price for a reason. Most presume they're destined for bankruptcy. But these seven may survive: they actually make money.
Despite Legal Drama, Catalyst Pharmaceuticals Looks Oversold
Catalyst Pharmaceuticals stock has been on a wild ride since its drug got FDA approval -- and despite legal drama, it may be worth the risk.
Why Catalyst Pharmaceuticals Stock Is Feeling the ‘Bern’
Typically, a major clinical victory would boost names like Catalyst Pharmaceuticals stock. Unfortunately, some political rumblings and an unexpected competitor got in the way of CPRX.
9 Robinhood Stocks Flying Under the Radar
Robinhood stocks have generated much attention this year, but here are some names that you may not have heard about.
4 Strong Buy Biotech Stocks With Upcoming FDA Decisions
These biotech stocks have fast-approaching PDUFA dates. Biotechs can soar or plunge on FDA decisions. These four pharma stocks should soar.
26 Biotechnology Stocks to Sell Now
The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
23 Biotechnology Stocks to Sell Now
The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Stocks Celebrate GOP Win on Bipartisan Hopes
Now on the horizon: The ECB, payrolls and Friday's showdown between President Obama and congressional leaders.
5 Red-Hot Biotech Stocks to Buy
Investors have been chasing risk again, buying up biotech stocks. Here's our list of the best biotech stocks out there.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
Sell